EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency

Kate Maresh iD, Andriani Papageorgiou, Deborah Ridout, Neil A Harrison, William Mandy, David Skuse, Francesco Muntoni

Brain · 2023

DOI: 10.1093/brain/awac048 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Brain, 2023. Verfasst von Kate Maresh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Great Ormond Street Hospital Children’s Charity, MRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is characterized by loss of dystrophin in muscle, however patients also have variable degree of intellectual disability and neurobehavioural co-morbidities. In contrast to muscle, in which a single full-length dystrophin isoform (Dp427) is produced, multiple isoforms are produced in the brain, and their deficiency accounts for the variability of CNS manifestations, with increased risk of comorbidities in patients carrying mutations affecting the 3′ end of the gene, which disrupt expression of shorter Dp140 and Dp71 isoforms. A mouse model (mdx mouse) lacks Dp427 in muscle and CNS and exhibits exaggerated startle responses to threat, linked to the deficiency of dystrophin in limbic structures such as the amygdala, which normalize with postnatal brain dystrophin-restoration therapies. A pathological startle response is not a recognized feature of DMD, and its characterization has implications for improved clinical management and translational research. To investigate startle responses in DMD, we used a novel fear-conditioning task in an observational study of 56 males aged 7–12 years (31 affected boys, mean age 9.7 ± 1.8 years; 25 controls, mean age 9.6 ± 1.4 years). Trials of two neutral visual stimuli were presented to participants: one ‘safe’ cue presented alone; one ‘threat’ cue paired with an aversive noise to enable conditioning of physiological startle responses (skin conductance response and heart rate). Retention of conditioned physiological responses was subsequently tested by presenting both cues without the aversive noise in an ‘Extinction’ phase. Primary outcomes were the initial unconditioned skin conductance and change in heart rate responses to the aversive ‘threat’ and acquisition and retention of conditioned responses after conditioning. Secondary and exploratory outcomes were neuropsychological measures and genotype associations. The mean unconditioned skin conductance response was greater in the DMD group than controls [mean difference 3.0 µS (1.0, 5.1); P = 0.004], associated with a significant threat-induced bradycardia only in the patient group [mean difference –8.7 bpm (–16.9, –0.51); P = 0.04]. Participants with DMD found the task more aversive than controls, with increased early termination rates during the Extinction phase (26% of DMD group versus 0% of controls; P = 0.007). This study provides the first evidence that boys with DMD show similar increased unconditioned startle responses to threat to the mdx mouse, which in the mouse respond to brain dystrophin restoration. Our study provides new insights into the neurobiology underlying the complex neuropsychiatric co-morbidities in DMD and defines an objective measure of this CNS phenotype, which will be valuable for future CNS-targeted dystrophin-restoration studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DystrophinMuscular Dystrophy, DuchenneMaleBiomarkersBrainProtein IsoformsReflex, StartleHumansChild

Stichwörter der Autor:innen

Duchenne muscular dystrophyanxietybraindystrophinfear conditioning

Substanzen

BiomarkersDystrophinProtein Isoforms

Autor:innen und Institutionen

  • Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Queen Square Centre for Neuromuscular Diseases, University College London, London WC1N 3BG, UK.
  • Population, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • NIHR Great Ormond Street Hospital Biomedical Research Centre, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
  • Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
  • Department of Clinical, Educational and Health Psychology, University College London, London WC1E 6BT, UK.

ORCID-Profile: Kate Maresh

Förderung

  • Medical Research Council
  • Great Ormond Street Hospital Children’s Charity
  • MRC
  • Brain Involvement iN Dystrophinopathies

Zitieren

APA

Maresh, K., Papageorgiou, A., Ridout, D., Harrison, N. A., Mandy, W., Skuse, D., & Muntoni, F. (2023). Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency. Brain. https://doi.org/10.1093/brain/awac048

Vancouver

Maresh K, Papageorgiou A, Ridout D, Harrison NA, Mandy W, Skuse D, et al. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency. Brain. 2023. doi:10.1093/brain/awac048

BibTeX
@article{Maresh2023,
  author = {Maresh, Kate and Papageorgiou, Andriani and Ridout, Deborah and Harrison, Neil A and Mandy, William and Skuse, David and Muntoni, Francesco},
  title = {Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awac048}
}
Kostenlos starten →